JAV

Javelin Energy Releases Second Quarter 2008 Financial Results - 11/28 - 02:49 PM ET

Javelin Pharmaceuticals to reduce workforce by 15% - 11/17 - 09:48 AM ET

Equedia: Analyst Ratings and Insider Trades for Javelin Pharmaceuticals, Inc. - 11/14 - 12:49 PM ET

BRIEF-Javelin reduces workforce by 15 pct - 11/14 - 10:07 AM ET

Javelin Pharmaceuticals Announces 15 Percent Reduction in Workforce - 11/14 - 10:05 AM ET

BRIEF-Javelin Pharmaceuticals Q3 results - 11/10 - 07:34 AM ET

Javelin Pharmaceuticals, Inc. Reports Third Quarter 2008 Results and Corporate Highlights - 11/10 - 07:28 AM ET

JAV: Q3 Earnings Call @ 08:30 ET Today [delayed] - 11/10 - 05:50 AM ET

Javelin Pharmaceuticals to Review Third Quarter 2008 Financial Results - 11/06 - 07:40 AM ET

Javelin initiates enrollment for Phase III pain trial - 09/23 - 10:57 AM ET

JAV: To Present At UBS Global Life Sciences Conference @ 12:00 ET [delayed] - 09/22 - 10:23 AM ET

JAV: Enrollment Begins for Ph 3 Trial of Dyloject(TM) - 09/22 - 08:41 AM ET

Javelin Enrolls First Patient in an Open Label Safety Study of Dyloject(TM) - 09/22 - 07:45 AM ET

Javelin completes enrollment for second Phase III study of pain drug - 09/17 - 10:35 AM ET

Javelin Pharmaceuticals to Present at the 2008 UBS Global Life Sciences Conference - 09/17 - 08:15 AM ET

JAV: Completes Enrollment in Second Phase 3 Trial of Dyloject(TM) - 09/16 - 08:47 AM ET

Javelin Pharmaceuticals Completes Patient Enrollment for Second of two Pivotal Phase 3 Studies of Dyloject(TM) - 09/16 - 08:00 AM ET

JAV: To Present At BioCentury's Biotech Industry Conference @ 11:30 ET [delayed] - 09/04 - 09:56 AM ET

Javelin Energy Releases First Quarter Financial Results - 08/29 - 05:00 PM ET

Javelin Pharmaceuticals CEO to Provide Corporate Overview at the BioCentury NewsMakers Conference - 08/26 - 08:55 AM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index